MedDataX Logo

Femoral Artery Crossover Rates in 1000 Consecutive Radial Cath Labs Procedures.

NCT ID: NCT02711514

Last Updated: 2021-02-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-12-31

Study Completion Date

2020-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of Crossover rates of Radial Cardiac Catheterizations and/or PCIs into femoral vs published literature

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Femoral Micropuncture or Routine Introducer Study

NCT01103141

Complications
TERMINATED NA

Radial Versus Femoral Arterial Access for Cardiac Catheterization: Comparison of Complications at 30 Days

NCT01019330

Radial Artery Occlusion
COMPLETED

Prevention of Radial Artery Occlusion After Trans-radial Cardiac Catheterization

NCT03182530

CARDIAC CATHETRIZATION
UNKNOWN NA

Use of the Venous Coupler in Breast Reconstruction by Means of a Deep Inferior Epigastric Perforator: Reduction of Surgery Length and Venous Thromboses ?

NCT03340623

Mammary Reconstruction
COMPLETED

Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality

NCT03594175

Catheter Occlusion Thrombosis
TERMINATED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A retrospective review of 1000 consecutive Radial or Ulnar Cardiac Catheterizations and/or Percutaneous Coronary Interventions performed in our Institute by one single operator could provide us with the cross over rates to femoral interventions. In this manner these rates could be compared to the published rates of other institutions benchmarking our techniques with the outcomes for such interventions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retrospective Review

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients coming to the emergency room requiring Diagnostic Cardiac Catheterizations and/or Percutaneous Coronary Interventions

Exclusion Criteria

* Cardiac Tamponade
* Cardiogenic Shock
Minimum Eligible Age

35 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Miami Cardiac and Vascular Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Raul Herrera, MD

Director Cardiac and Vascular Institute

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ramon Quesada, MD

Role: PRINCIPAL_INVESTIGATOR

Director Structural Heart BHSF

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Miami Cardiac and Vascular Institute

Miami, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JR1000R

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Assessment of Distal Protection Device in Patients at High Risk for Distal Embolism in Acute Coronary Syndrome (ACS)
NCT01460966 COMPLETED NA
Micropuncture vs. Standard Common Femoral Artery Access
NCT02026180 TERMINATED NA
Femoral or Radial Approach in Coronary Chronic Total Occlusion
NCT03265769 COMPLETED NA
Risk Factors for Thrombosis in Children With Central Venous Lines
NCT04117217 COMPLETED
Comparison of Distal and Proximal Radial Artery Patency Following Coronary Catheterization, A Real Look at a Special Community
NCT07138170 NOT_YET_RECRUITING NA
Characteristics Predictive of Success and Complications in the Use of Suture-Mediated Closure of Femoral Venous Access
NCT00838175 UNKNOWN
Left Versus Right Transradial Approach for Percutaneous Coronary Procedures
NCT00821106 COMPLETED NA
Safety and Feasibility of the Infinity Catheter for Radial Access
NCT04553549 COMPLETED
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters
NCT00346424 COMPLETED PHASE3
A Single Center Study to Evaluate the Safety of the NovaCross Microcatheter in Crossing Chronic Total Occlusions
NCT04862559 COMPLETED NA
3D US Guided Femoral Artery Access for TAVI
NCT04691245 UNKNOWN NA
A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO).
NCT02358629 COMPLETED NA
Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System
NCT01121510 WITHDRAWN PHASE1/PHASE2
Study to Compare CAUTI Rates Following ERASE CAUTI Tray Silver vs Silver Coated Foley Catheters
NCT02915692 TERMINATED
Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices
NCT00073515 COMPLETED PHASE2
Midline Catheter and Its Impact on Central Lines Removal in ICU
NCT03675711 TERMINATED NA
RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial
NCT01446263 COMPLETED PHASE3
Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose
NCT00507013 COMPLETED PHASE1/PHASE2
Novel Strategy to Encourage Early Removal of Central Venous Catheters
NCT04136561 WITHDRAWN NA
Peripheral Facilitated Antegrade Steering Technique in Chronic Total Occlusions
NCT01246505 COMPLETED PHASE3
Postcath Radial Arterial Clamp Time In the CAth Lab
NCT02269722 COMPLETED PHASE3
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
NCT01271946 COMPLETED NA
Endovascular Modalites for Contralateral Common Iliac Artery in Patients With Symptomatic Unilateral Common Iliac Artery Occlusive Disease
NCT07012551 NOT_YET_RECRUITING
Creation of a Vascular Access Specialist Teams Within an Interventional Vascular Radiology Service: a Retrospective Observational Study
NCT06770361 COMPLETED
Chronic Total Occlusion Crossing With the Wildcat Catheter
NCT01174784 COMPLETED NA